Improvements with tiotropium in COPD patients with concomitant asthma

Respiratory Medicine

Volumn 102, Issue 1, 2008, Pages 50-56

  Magnussen, H ^a   Bugnas, B ^b   van Noord, J ^c   Schmidt, P ^d   Gerken, F ^d   Kesten, S ^d  

^a KRANKENHAUS GROSSHANSDORF   (Germany)

^b Sittard Geleen Heerlen   (Netherlands)

^c Cabinet de Pneumologie   (France)

^d BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Asthma; Bronchodilators; Chronic obstructive lung disease; Spirometry; Tiotropium

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHROMONE DERIVATIVE; CORTICOSTEROID; IPRATROPIUM BROMIDE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PLACEBO; PREDNISONE; SALBUTAMOL; STEROID; THEOPHYLLINE; TIOTROPIUM BROMIDE;

ADULT; AREA UNDER THE CURVE; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FORCED EXPIRATORY VOLUME; GASTROINTESTINAL DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MULTICENTER STUDY; OUTCOME ASSESSMENT; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; SPIROMETRY; TREATMENT DURATION;

ASTHMA; BRONCHODILATOR AGENTS; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MIDDLE AGED; PEAK EXPIRATORY FLOW RATE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SCOPOLAMINE DERIVATIVES; SPIROMETRY; TREATMENT OUTCOME;

EID: 36349023217     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2007.08.003     Document Type: Article

References (26)

1. Pauwels R.A., Buist A.S., Calverley P.M.A., et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary. Am J Respir Crit Care Med 163 (2001) 1256-1276
2. National Institutes of Health (National Heart, Lung and Blood Institute). Global initiative for asthma; global strategy for asthma management and prevention. Bethesda, MD: National Institutes of Health; 2002 April, Publication no. 02-3659.
3. Fabbri L.M., Romagnoli M., Corbetta L., et al. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med 167 (2003) 418-424
4. Soriano J.B., Davis K.J., Coleman B., et al. The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom. Chest 124 (2003) 474-481
5. Lanes S.F., Garrett J.E., Wentworth C.E., et al. The effect of adding ipratropium bromide to salbutamol in the treatment of acute asthma: a pooled analysis of three trials. Chest 114 (1998) 365-372
6. Rodrigo G., Rodrigo C., and Burschtin O. A meta-analysis of the effect of ipratropium bromide in adults with acute asthma. Am J Med 107 (1999) 363-370
7. Israel E., Chinchilli V.M., Ford J.G., et al. Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. Lancet 364 (2004) 1505-1512
8. Casaburi R., Mahler D.A., Jones P.W., et al. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J 19 (2002) 217-224
9. Brusasco V., Hodder R., Miravitlles M., et al. Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD. Thorax 58 (2003) 399-404
10. Niewoehner D., Rice K., Cote C., et al. Prevention of exacerbations of COPD with tiotropium, a once-daily inhaled anticholinergic bronchodilator. Ann Intern Med 143 (2005) 317-326
11. Celli B.R., and MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 23 6 (2004) 932-946
12. American Thoracic Society. Standardization of spirometry-1994 update. Am J Respir Crit Care Med 152 (1995) 1107-1136
13. Dusser D., Bravo M.L., Iacono P., and on behalf of the MISTRAL study group. The effect of tiotropium on exacerbations and airflow in patients with COPD. Eur Respir J 27 (2006) 547-555
14. Nutritional Center for Health Statistics. NHANES III reference manuals and reports. Hyattsville, MD: National Center for Health Statistics, Data Dissemination Branchy; 1996, CD-ROM No. 6-1078 (1096).
15. Orie N.G.M., Sluiter H.J., De Vries K., et al. The host factor in bronchitis. In: Orie N.G.M., and Sluiter H.J. (Eds). Bronchitis (1961), Royal Van Gorcum, Assen, The Netherlands 43-59
16. Vermeire P.A., and Pride N.B. A"Splitting" look at chronic nonspecific lung disease (CNSLD): common features but diverse pathogenesis. Eur Respir J 4 (1991) 490-496
17. Wenzel S.E., Schwartz L.B., Langmack E.L., et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 160 (1999) 1001-1008
18. Saetta M., Di Stefano A., Maestrelli P., et al. Airway eosinophilia in chronic bronchitis during exacerbations. Am J Respir Crit Care Med 150 (1994) 1646-1652
19. Kesten S., and Rebuck A.S. Is the short-term response to inhaled beta-adrenergic agonist sensitive or specific for distinguishing between asthma and COPD?. Chest 105 (1994) 1042-1045
20. Jeffery P.K. Structural and inflammatory changes in COPD: a comparison with asthma. Thorax 53 (1998) 129-136
21. Fabbri L.M., Romagnoli M., Corbetta L., et al. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med 167 (2003) 418-424
22. O'Donnell D., Flüge T., Gerken F., et al. Effects of tiotropium on lung hyperinflation, dyspnoea, and exercise tolerance in patients with COPD. Eur Respir J 23 (2004) 832-840
23. Magnussen H., Richter K., and Taube C. Are chronic obstructive pulmonary disease (COPD) and asthma different diseases. Clin Exp Allergy 28 Suppl. 5 (1998) 187-194
24. Mannino D.M., Gagnon R.C., Petty T.L., et al. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 160 (2000) 1683-1689
25. Celli B., Tashkin D., Decramer M., et al. Acute bronchodilator responsiveness in a global respiratory trial (UPLIFT) following maximal inhaled bronchodilators. Eur Respir J 26 (2005) 716S
26. Tashkin D., and Kesten S. Long term treatment benefits with tiotropium in COPD patients with and without acute bronchodilator responses. Chest 123 (2003) 1441-1449